OPTUS Pharmaceutical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	87,161	81,905	72,426	58,658	57,316
Other Revenue	-	-0	-0	-	-
Revenue	87,161	81,905	72,426	58,658	57,316
Revenue Growth (YoY)	6.42%	13.09%	23.47%	2.34%	-5.77%
Cost of Revenue	39,037	37,277	31,072	27,041	24,821
Gross Profit	48,125	44,628	41,354	31,617	32,495
Selling, General & Admin	35,846	32,846	30,623	24,138	20,589
Research & Development	1,731	1,883	1,384	1,343	1,110
Other Operating Expenses	234.12	260.69	164.19	184.49	110.92
Operating Expenses	39,249	36,119	33,168	26,368	22,023
Operating Income	8,875	8,509	8,187	5,249	10,472
Interest Expense	-69.34	-97.24	-124.4	-85.89	-8.88
Interest & Investment Income	1,328	2,373	2,296	1,401	846.43
Currency Exchange Gain (Loss)	216.69	84.8	3.33	12.17	127.54
Other Non Operating Income (Expenses)	281.91	-469.62	11.79	21.69	-36.76
EBT Excluding Unusual Items	10,633	10,400	10,374	6,598	11,400
Gain (Loss) on Sale of Investments	16.32	1,242	1,967	73.39	-
Gain (Loss) on Sale of Assets	1,939	441.87	629.3	878.29	44.24
Asset Writedown	-1,536	-	-	-721.2	-964.98
Pretax Income	11,052	12,084	12,970	6,828	10,479
Income Tax Expense	-305.86	1,776	2,210	1,816	587.88
Net Income	11,358	10,308	10,760	5,012	9,892
Net Income to Common	11,358	10,308	10,760	5,012	9,892
Net Income Growth	10.18%	-4.20%	114.69%	-49.33%	-31.33%
Shares Outstanding (Basic)	16	15	15	16	16
Shares Outstanding (Diluted)	16	15	15	16	16
Shares Change (YoY)	1.88%	0.53%	-4.22%	-1.07%	-0.62%
EPS (Basic)	731.00	675.00	708.35	316.00	617.00
EPS (Diluted)	730.00	675.00	708.35	316.00	617.00
EPS Growth	8.15%	-4.71%	124.16%	-48.78%	-30.91%
Free Cash Flow	-28,290	-2,903	9,109	-3,955	-3,557
Free Cash Flow Per Share	-1818.26	-190.11	599.63	-249.37	-221.87
Gross Margin	55.21%	54.49%	57.10%	53.90%	56.69%
Operating Margin	10.18%	10.39%	11.30%	8.95%	18.27%
Profit Margin	13.03%	12.59%	14.86%	8.54%	17.26%
Free Cash Flow Margin	-32.46%	-3.55%	12.58%	-6.74%	-6.21%
EBITDA	13,583	12,486	12,424	8,712	12,895
EBITDA Margin	15.58%	15.24%	17.15%	14.85%	22.50%
D&A For EBITDA	4,708	3,977	4,238	3,463	2,423
EBIT	8,875	8,509	8,187	5,249	10,472
EBIT Margin	10.18%	10.39%	11.30%	8.95%	18.27%
Effective Tax Rate	-	14.69%	17.04%	26.60%	5.61%
Advertising Expenses	1,033	2,032	1,515	364.81	100.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.